Literature DB >> 26576967

Symptom burden in long-term germ cell tumor survivors.

Karin Oechsle1, Michael Hartmann2, Anja Mehnert3,4, Christoph Oing5, Carsten Bokemeyer5, Sigrun Vehling3.   

Abstract

PURPOSE: Testicular germ cell tumor (GCT) and its treatment may cause distressing long-term symptoms. We aimed to examine self-reported symptom frequency and distress as well as the impact of demographic and medical characteristics in GCT survivors.
METHODS: A total of 164 GCT survivors receiving follow-up care at the University Cancer Center Hamburg and a specialized private practice facility were interviewed at a median time of 11.6 years after first diagnosis. Metastatic disease was present in 48 % of the patients and relapse had occurred in 17 %. The patients completed the short form of the Memorial Symptom Assessment Scale (MSAS-SF) assessing 28 physical and 4 psychological symptoms.
RESULTS: The mean number of physical symptoms was 4.5 (SD = 4.3) (psychological symptoms M = 1.4, SD = 1.4; total M = 5.9, SD = 5.2). The most frequent physical symptoms were lack of energy (49 %), feeling drowsy (42 %), sleeping problems (36 %), and difficulty in concentration (32 %). Lack of energy was experienced as highly distressing by 21 % of the patients. The most frequent psychological symptoms were irritability (47 %) and being worried (42 %). The number of physical symptoms was associated with higher age, lower socioeconomic status, and shorter time since diagnosis in multivariate regression analyses controlling for metastatic vs. localized disease, relapse, extent of surgery, number of chemotherapy cycles, and radiotherapy.
CONCLUSIONS: GCT survivors suffered from a significant number of long-term symptoms. Fatigue-related symptoms were most frequent and perceived as highly distressing. Continuous attention toward fatigue is necessary throughout follow-up care to offer support in time, particularly in more vulnerable patients of higher age and lower socioeconomic status.

Entities:  

Keywords:  Distress; Germ cell tumor; Survivor; Symptom burden; Testicular cancer

Mesh:

Year:  2015        PMID: 26576967     DOI: 10.1007/s00520-015-3026-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  23 in total

Review 1.  Testicular cancer--discoveries and updates.

Authors:  Nasser H Hanna; Lawrence H Einhorn
Journal:  N Engl J Med       Date:  2014-11-20       Impact factor: 91.245

2.  Prevalence, changes in and correlates of fatigue in the first year after diagnosis of testicular cancer.

Authors:  Joke Fleer; Dirk T Sleijfer; Harald J Hoekstra; Marrit A Tuinman; Josette E H M Hoekstra-Weebers
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

Review 3.  Sequelae of treatment in long-term survivors of testis cancer.

Authors:  Robert Abouassaly; Sophie D Fossa; Aleksander Giwercman; Christian Kollmannsberger; Robert J Motzer; Hans-Joachim Schmoll; Cora N Sternberg
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

4.  Sexuality and body image in long-term survivors of testicular cancer.

Authors:  P Rossen; A F Pedersen; R Zachariae; H von der Maase
Journal:  Eur J Cancer       Date:  2011-12-23       Impact factor: 9.162

5.  Fatigue, anxiety, and depression in long-term survivors of testicular cancer.

Authors:  Sophie D Fosså; Alv A Dahl; Jon H Loge
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

6.  Treatment of testicular cancer: a new and improved model.

Authors:  L H Einhorn
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

7.  Sexual function in men treated for testicular cancer.

Authors:  Jakob Eberhard; Olof Ståhl; Gabriella Cohn-Cedermark; Eva Cavallin-Ståhl; Yvonne Giwercman; Lars Rylander; Malin Eberhard-Gran; Ulrik Kvist; Kerstin S Fugl-Meyer; Aleksander Giwercman
Journal:  J Sex Med       Date:  2009-04-28       Impact factor: 3.802

8.  Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.

Authors:  Hege S Haugnes; George J Bosl; Hink Boer; Jourik A Gietema; Marianne Brydøy; Jan Oldenburg; Alv A Dahl; Roy M Bremnes; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Chronic cancer-related fatigue in long-term survivors of testicular cancer.

Authors:  Ingrid J Orre; Sophie D Fosså; Robert Murison; Roy Bremnes; Olav Dahl; Olbjørn Klepp; Jon H Loge; Erik Wist; Alv A Dahl
Journal:  J Psychosom Res       Date:  2008-04       Impact factor: 3.006

10.  Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.

Authors:  Sanne B Schagen; Willem Boogerd; Martin J Muller; Wim Ten Bokkel Huinink; Luc Moonen; Wim Meinhardt; Frits S A M Van Dam
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

View more
  6 in total

Review 1.  Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers.

Authors:  Risa L Wong; Alicia K Morgans
Journal:  Curr Oncol Rep       Date:  2020-02-08       Impact factor: 5.075

Review 2.  Identifying the unmet supportive care needs of individuals affected by testicular cancer: a systematic review.

Authors:  R Doyle; P Craft; M Turner; C Paterson
Journal:  J Cancer Surviv       Date:  2022-07-04       Impact factor: 4.442

Review 3.  Testicular cancer survivorship: Long-term toxicity and management.

Authors:  Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

4.  Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors.

Authors:  Scott C Adams; Darren S DeLorey; Margie H Davenport; Adrian S Fairey; Scott North; Kerry S Courneya
Journal:  Br J Cancer       Date:  2018-05-08       Impact factor: 7.640

Review 5.  Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches.

Authors:  Mario Uccello; Stergios Boussios; Eleftherios P Samartzis; Michele Moschetta
Journal:  Ann Transl Med       Date:  2020-12

Review 6.  Patient-Reported Outcomes Associated with Treatments for Testicular Cancer: A Systematic Review.

Authors:  Rebecca Mercieca-Bebber; Sayeda Kamrun Naher; Orlando Rincones; Allan Ben Smith; Martin R Stockler
Journal:  Patient Relat Outcome Meas       Date:  2021-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.